Farmaprojects started its activities in 1988 providing Regulatory Affairs services to third party companies.
In the following years, it rapidly expanded its scope and started to prepare generic product dossiers for other pharmaceutical companies. Later it began to develop its own generic products and MA dossiers with the aim of licensing them to third parties and supplying the finished products to customers worldwide.
Farmaprojects is a pharmaceutical company that has been successfully present in the generics market for more than two decades. Our privileged position in the market demands and enables our team to be dynamic, fast responders and adaptable to our partners’ needs. It also allows us to seek new opportunities in the pharmaceutical products’ market.
At the beginning of 2006, Farmaprojects entered into a strategic alliance with Polpharma Group. In 2013, after seven years of successful cooperation, the B2B venture between Polpharma Group and Farmaprojects initiated activities. This B2B activity offers a high quality portfolio of products and services: Fine Chemicals supply, Licensing out of generic product dossiers with Finished Dosage Forms supply and Contract Manufacturing services. In addition, we offer full support in Regulatory Affairs an Intellectual Property regarding our dossiers.
We are always seeking partners who wish to in-license and commercialize products from our portfolio all around the world.
Meeting challenges is our daily motivation. Five essential pillars support our main objective: Your success is what matters to us
- High Quality Dossiers
- Intellectual Property Support
- Regulatory Affairs Support
- Pricing Optimization
- Smooth Process of launching